ConductScience.org, home

Paper776335

Immune response to HBsAg and the spectrum of liver lesions in HBsAg-positive patients with chronic renal disease.

Galbraith RM and 7 others. Br Med J, 1976. Cited by 14 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Immune response to HBsAg and the spectrum of liver lesions in HBsAg-positive patients with chronic renal disease. Papers, record 776335. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/776335

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immune response to HBsAg and the spectrum of liver lesions in HBsAg-positive patients with chronic renal disease.
PubMed
Journal
Br Med J
PubMed
Year
1976
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
0.78
iCite
Revised in PubMed
2019-05-01
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Galbraith RMR M
2el Sheikh NN
3Portmann BB
4Eddleston ALA L
5Williams RR
6Parsons VV
7Bewick MM
8Ogg CSC S

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hepatitis B AntigensMajor topic
Kidney Failure, ChronicMajor topic
Liver DiseasesMajor topic
Adult
Female
Hepatitis
Humans
Immunity, Cellular
Immunosuppressive Agents
Kidney Transplantation
Liver
Male
Middle Aged
Renal Dialysis
Transplantation, Homologous

Source PubMed

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14,577,389Hepatitis affecting hemodialysis and transplant patients. Its considerations and consequences.Arch Intern Med1973https://conductscience.org/library/papers/4577389PubMed
25,578,233Defective cellular immunity in renal failure: depression of reactivity of lymphocytes to phytohemagglutinin by renal failure serum.J Clin Invest1971https://conductscience.org/library/papers/5578233PubMed
34,850,682Asymptomatic liver disease in hepatitis B antigen carriers.J Clin Pathol1974https://conductscience.org/library/papers/4850682PubMed
44,587,828Immunological studies of Australia antigen carriers with and without liver diseases.Clin Exp Immunol1973https://conductscience.org/library/papers/4587828PubMed
54,562,099Irreversible liver damage after azathioprine.JAMA1972https://conductscience.org/library/papers/4562099PubMed
64,577,390Liver disease in kidney transplant patients receiving azathioprine.Arch Intern Med1973https://conductscience.org/library/papers/4577390PubMed
74,125,788Detection of hepatitis-B antigen by radioimmunoassay in chronic liver disease and hepatocellular carcinoma in Great Britain.Lancet1973https://conductscience.org/library/papers/4125788PubMed
84,111,197Cellular immunity and hepatitis-associated, Australia antigen liver disease.Lancet1972https://conductscience.org/library/papers/4111197PubMed
94,140,983Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.Lancet1974https://conductscience.org/library/papers/4140983PubMed
1045,864A new antigen-antibody system. Clinical significance in long-term carriers of hepatitis B surface antigen.JAMA1975https://conductscience.org/library/papers/45864PubMed
1157,904Detection of HBSAG in fixed liver tissue - use of a modified immunofluorescent technique and comparison with histochemical methods.Gut1976https://conductscience.org/library/papers/57904PubMed
121,080,125Cell-mediated immunity to hepatitis B surface antigen in blood donors with persistent antigenaemia.Gut1975https://conductscience.org/library/papers/1080125PubMed
1351,345Fulminant hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy.Lancet1975https://conductscience.org/library/papers/51345PubMed
14164,401Spectrum of liver disease in renal transplant recipients.Gastroenterology1975https://conductscience.org/library/papers/164401PubMed
151,089,835Pattern of core and surface expression in liver tissue reflects state of specific immune response in hepatitis B.Lab Invest1975https://conductscience.org/library/papers/1089835PubMed
161,192,012e Antigen-antibody system as indicator of liver damage in patients with hepatitis-B antigen.Br Med J1975https://conductscience.org/library/papers/1192012PubMed

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
7,380,332Liver disease and the e antigen in HBsAg carriers with chronic renal failure.Gut1980https://conductscience.org/library/papers/7380332PubMed
6,426,696Negative selection of patients for dialysis and transplantation in the United Kingdom.Br Med J (Clin Res Ed)1984https://conductscience.org/library/papers/6426696PubMed
1,276,811Letter: Hepatitis in patients with chronic renal failure.Br Med J1976https://conductscience.org/library/papers/1276811PubMed
322,505Pathologic aspects of cirrhosis. A review.Am J Pathol1977https://conductscience.org/library/papers/322505PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/776335

GET https://conductscience.org/api/papers/v1/776335/authors